4/16/2014 7:06:24 AM
Consumer goods maker Reckitt Benckiser Group stood by its 2014 financial targets on Wednesday despite unusually weak sales of disinfectants and signalled it was leaning toward spinning off its declining pharmaceuticals business. The British company said a strategic review of Reckitt Benckiser Pharmaceuticals (RBP) that it launched in October was progressing well and that a "capital markets solution is emerging as a strong option". "We mean that RBP would be an independent, publicly listed company," said Chief Financial Officer Adrian Hennah, although he noted that all options including selling or keeping it remained on the table.
Help employers find you! Check out all the jobs and post your resume.
comments powered by